Prostate cancer in relation to the use of electric blanket or heated water bed

Epidemiology

Volumn 10, Issue 1, 1999, Pages 83-85

  Zhu, Kangmin ^a   Weiss, Noel S ^b   Stanford, Janet L ^c   Daling, Janet R ^b   Stergachis, Andy ^b   McKnight, Barbara ^b   Brawer, Michael K ^d   Levine, Robert S ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c USA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Age; Case control studies; Electric bedding devices; Electromagnetic fields; Prostate neoplasms

Indexed keywords

MELATONIN;

ADULT; AGE; AGED; ARTICLE; BED; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; REGRESSION ANALYSIS; UNITED STATES;

EID: 0032900485     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199901000-00016     Document Type: Article

References (21)

1. Bates MN. Extremely low frequency electromagnetic fields and cancer: the epidemiologic evidence. Environ Health Perspect 1991;95:147-156.
2. Savitz DA. Overview of epidemiologic research on electric and magnetic fields and cancer. Am Ind Hyg Assoc J 1993;54:197-204.
3. Heath CW, Jr. Electromagnetic field exposure and cancer: a review of epidemiologic evidence. CA Cancer J Clin 1996;65:29-44.
4. Stevens RG. Biologically based epidemiological studies of electric power and cancer. Environ Health Perspect 1993;101(Suppl 4):93-100.
5. Zhu K, Stanford JL, Daling JR, McKnight B, Stergachis A, Brawer MK, Weiss NS. Vasectomy and prostate cancer: a case-control study in a health maintenance organization. Am J Epidemiol 1996;144:717-722.
6. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol 1. The Analysis of Case-Control Studies. IARC Scientific Pub. No. 32. Lyon: International Agency for Research and Cancer, 1980.
7. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
8. Delpizzo V. A model to assess personal exposure to ELF magnetic fields from common household sources. Bioelectromagnetics 1990;11:139-147.
9. Wilson BW, Anderson LE, Hilton DI, Philips RD. Chronic exposure to 60-Hz electric fields: effects on pineal function in the rat. Bioelectromagnetics 1981;2:371-80.
10. Reiter RJ, Anderson LE, Buschbom RL, Wilson BW. Reduction of the nocturnal rise in pineal melatonin levels in rats exposed to 60-Hz electric fields in utero and for 23 days after birth. Life Sci 1988;42:2203-2206.
11. Kato M, Honma K, Shigemitsu T, Shiga Y. Effects of exposure to a circularly polarized 40-Hz magnetic field on plasma and pineal melatonin levels in rats. Bioelectromagnetics 1993;14:97-106.
12. Reiter RJ. Melatonin suppression by static and extremely low frequency electromagnetic fields: relationship to the reported increased incidence of cancer. Rev Environ Health 1994;10:171-186.
13. Wilson BW, Wright CW, Morris JE, Buschbom RL, Brown DP, Miller DL, Sommers-Flannigan R, Anderson LE. Evidence for an effect of ELF electromagnetic fields on human pineal gland function. J Pineal Res 1990;9:259-269.
14. Selmaoui B, Lambrozo J, Touitou Y. Magnetic fields and pineal function in humans: evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms. Life Sci 1996;58:1539-1549.
15. Graham C, Cook MR, Riffle DW. Human melatonin during continuous magnetic field exposure. Bioelectromagnetics 1997;18:166-171.
16. Reiter RJ. Effects of light and stress on pineal function. In: Wilson BW, Stevens RG, Anderson LE, eds. Extremely Low Frequency Electromagnetic Fields: The Question of Cancer. Columbus, OH: Battelle Press, 1990;87-107.
17. Moon TD, Sloane BB. Prostatic adenocarcinoma: carcinogenesis and growth. J Am Geriatr Soc 1989;37:55-64.
18. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977;37:1929-1933.
19. Hutchinson GB. Incidence and etiology of prostate cancer. Urology 1981; 17(Suppl 3):4-10.
20. Griffiths K, Davies P, Eaton CL, Harper ME, Peeling WB, Turkes AO, Turkes A, Wilson DW, Pierrepoint CG. Cancer of the prostate: endocrine factors. Oxf Rev Reprod Biol 1987;9:192-259.
21. Bartsch C, Bartsch H, Schmidt A, Ilg S, Bichler KH, Fluchter SH. Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations. Clin Chim Acta 1992; 209:153-167.